Nylidrin hydrochloride - CAS 849-55-8
Catalog number:
849-55-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H26NO2Cl
Molecular Weight:
335.87
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Nylidrin hydrochloride is a beta-adrenergic agonist. It was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and of IgG1-mediated release of histamine from passively sensitized guinea pig lung slices. It causes peripheral vasodilation, a positive inotropic effect, and increases gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor. It also can be used as antiallergic agent. It is one of the FDA approved drug as Inhibitors of the Human Sodium Taurocholate Cotransporting Polypeptide (NTCP).
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
Off-White Solid
Synonyms:
1-p-Hydroxyphenyl-2-(1’-methyl-3’-phenylpropylamino)-1-propanolhydrochloride;Arlidin hydrochloride;Buphenine hydrochloride;Dilatol hydrochloride;p-Hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)-benzylalcohohyd;Suprifenpsb hydrochloride;4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride;Dilatyl
Solubility:
DMSO:38mg/mL
Storage:
Hygroscopic, -20˚C Freezer, Under Inert Atmosphere
MSDS:
Inquire
Application:
Nylidrin hydrochloride is used in the treatment of peripheral vascular disorders and premature labor. It also can be used as antiallergic agent.
Quality Standard:
USP standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams-Kilos
Melting Point:
198-199 °C (decomp)
InChIKey:
CLJHABUMMDMAFA-UHFFFAOYSA-N
InChI:
InChI=1S/C19H25NO2.ClH/c1-14(8-9-16-6-4-3-5-7-16)20-15(2)19(22)17-10-12-18(21)13-11-17;/h3-7,10-15,19-22H,8-9H2,1-2H3;1H
Canonical SMILES:
CC(CCC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O.Cl
1.Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
Tamiz AP1, Whittemore ER, Zhou ZL, Huang JC, Drewe JA, Chen JC, Cai SX, Weber E, Woodward RM, Keana JF. J Med Chem. 1998 Aug 27;41(18):3499-506.
A series of bis(phenylalkyl)amines, structural analogues of ifenprodil and nylidrin, were synthesized and tested for antagonism of N-methyl-D-aspartate (NMDA) receptors. Potency and subunit selectivity were assayed by electrical recordings in Xenopus oocytes expressing three binary combinations of cloned rat NMDA receptor subunits: NR1A expressed in combination with either NR2A, NR2B, or NR2C. The bis(phenylalkyl)amines were selective antagonists of NR1A/2B receptors. Assayed under steady-state conditions, the most potent of these, N-[2-(4-hydroxyphenyl)ethyl]-5-phenylpentylamine hydrochloride (20), has an IC50 value of 8 nM and >1000-fold selectivity with respect to NR1A/2A and NR1A/2C receptors. The structure-activity relationship of the bis(phenylalkyl)amine series indicates that the piperidine ring and alkyl chain substitutions common to NR2B-selective antagonists such as ifenprodil, CP 101,606, and Ro 25-6981 are not necessary to generate potent and selective ligands.
2.Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.
Bartlett H1, Eperjesi F. Ophthalmic Physiol Opt. 2003 Sep;23(5):383-99.
Age-related macular degeneration (AMD) is the leading cause of severe vision loss in the developed world. The lack of effective treatment modalities, coupled with evidence supporting an oxidative pathogenesis, has increased interest in the potential preventative role of nutritional supplementation. This article reviews seven randomised controlled trials (RCTs) that have investigated the role of nutritional supplementation in AMD. Three of these trials reported a positive effect of nutritional supplementation on AMD; the Age-related eye study (AREDS), the Lutein Antioxidant Supplementation Trial (LAST), and the oral zinc trial by Newsome et al. (1988). However, the oral zinc trial by Newsome et al. (1988) was unlikely to detect any difference between treatments smaller than 72%, and the AREDS results were based on a subgroup of their study population. Lutein was considered for the AREDS formulation, but was not commercially available at that time.
3.[Clinical trial on the effect of buphenine, aminophenazone and diphenylpyraline hydrochloride in treating the common cold in children of 6 to 24 months of age].
Montijo-Barrios E1, Cadena F, Ramírez-Mayans JA, Gutiérrez-Castrellón P. Rev Invest Clin. 2011 Jul-Aug;63(4):335-43.
INTRODUCTION: Acute respiratory infections are the second leading cause of morbidity in children under 18 years. Several drugs have been used with variable efficacy and safety, trying to reduce the associated symptoms and improve quality of life.
4.[3H]ifenprodil binding to NMDA receptors in porcine hippocampal brain membranes.
Höfner G1, Wanner KT. Eur J Pharmacol. 2000 Apr 14;394(2-3):211-9.
(+/-)-2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)propan-1-ol ([3H]ifenprodil) binding to a subcellular fraction of porcine hippocampus, which was obtained by centrifugation on a discontinuous sucrose gradient, was investigated with the objective to label selectively the ifenprodil recognition site of native NMDA receptors. Saturation experiments revealed high-affinity sites for [3H]ifenprodil in this membrane fraction which could be characterised by a K(d) value of 23.0+/-1.8 nM using a one-site model. Calculation of saturation isotherms on the basis of a two-site model yielded a K(d1) value of 10.4+/-2.4 nM and a K(d2) value of 2200+/-1300 nM, respectively. Inhibition of [3H]ifenprodil binding by NR2B subunit-selective NMDA receptor antagonists, by polyamines, by sigma receptor ligands, by a variety of ligands acting at different NMDA receptor recognition sites and by several cations was studied and compared with the effects of these compounds on (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) binding under non-equilibrium conditions.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 18559-94-9 Salbutamol

Salbutamol
(CAS: 18559-94-9)

Salbutamol is a short-acting agonist that specifically targets β2-adrenergic receptor to alleviate bronchospasm in conditions such as asthma and chronic obstruc...

CAS 318-98-9 Propranolol Hydrochloride

Propranolol Hydrochloride
(CAS: 318-98-9)

Propranolol hydrochloride, with antihypertensive, antianginal and antiarrhythmic (class II) properties, is a non-cardioselective adrenergic-beta antagonist and ...

Aptazapine maleate
(CAS: 71576-41-5)

Aptazapine is a tetracyclic antidepressant. It was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. Aptazapine is...

CAS 23256-50-0 Guanabenz Acetate

Guanabenz Acetate
(CAS: 23256-50-0)

Guanabenz Acetate is an selective agonist of α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor with pEC50 of 8.25, 7.01 and ~5, respe...

CAS 71576-40-4 Aptazapine

Aptazapine
(CAS: 71576-40-4)

Aptazapine is a tetracyclic antidepressant. It was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. Aptazapine is...

CAS 106463-17-6 Tamsulosin HCl

Tamsulosin HCl
(CAS: 106463-17-6)

The hydrochloride salt form of Tamsulosin which could block on the sympathetic α1 receptor, especially selectively bind to the α1A receptor so that has been fou...

CAS 63-92-3 Phenoxybenzamine HCl

Phenoxybenzamine HCl
(CAS: 63-92-3)

Phenoxybenzamine HCl is a non-specific, irreversible alpha antagonist with an IC50 of 550 nM.

CAS 61-76-7 Phenylephrine HCl

Phenylephrine HCl
(CAS: 61-76-7)

Phenylephrine HCl is a selective α1-adrenergic receptor agonist of the phenethylamine class used primarily as a decongestant, as an agent to dilate the pupil, a...

CAS 56-47-3 Deoxycorticosterone acetate

Deoxycorticosterone acetate
(CAS: 56-47-3)

Deoxycorticosterone acetate is a steroid hormone used for intramuscular injection for replacement therapy of the adrenocortical steroid.

CAS 29110-47-2 Guanfacine

Guanfacine
(CAS: 29110-47-2)

Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hyperactivity disorder (ADHD) and hypertension. It lowers bo...

CAS 6673-35-4 Practolol

Practolol
(CAS: 6673-35-4)

Practolol is a selective beta-1 adrenergic antagonist that has been used in the emergency treatment of cardiac arrhythmias. lt competes with adrenergic neurotra...

Batefenterol
(CAS: 743461-65-6)

Batefenterol is a Beta 2 adrenergic receptor agonist and also a Muscarinic receptor antagonist. It shows high affinity for hM2 (Ki = 1.4 nM), hM3 muscarinic rec...

Dobutamine HCl
(CAS: 49745-95-1)

Dobutamine is a sympathomimetic drug used in the treatment of heart failure and cardiogenic shock. Its primary mechanism is direct stimulation of β1 receptors o...

CAS 63659-18-7 Betaxolol

Betaxolol
(CAS: 63659-18-7)

Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.

CAS 86347-15-1 Medetomidine HCl

Medetomidine HCl
(CAS: 86347-15-1)

Medetomidine is a selective α2-adrenoceptor agonist, with Ki of 1.08 nM, exhibts 1620-fold selectivity over α1-adrenoceptor.

CAS 208992-74-9 Fiduxosin hydrochloride

Fiduxosin hydrochloride
(CAS: 208992-74-9)

Fiduxosin hydrochloride is an alpha(1)-adrenoceptor antagonist used for the treatment of benign prostatic hyperplasia.

CAS 72795-01-8 ICI 118551 hydrochloride

ICI 118551 hydrochloride
(CAS: 72795-01-8)

ICI 118551 hydrochloride is a highly selective β2 adrenergic antagonist (Ki values are 1.2, 120 and 257 nM for β2, β1 and β3 receptors respectively), inhibited ...

CAS 158599-53-2 Zoleprodolol

Zoleprodolol
(CAS: 158599-53-2)

Zoleprodolol, an oxadiazol derivative, has been found to be an adrenergic receptor antagonist.

CAS 18910-65-1 Salmefamol

Salmefamol
(CAS: 18910-65-1)

Salmefamol is a beta2-adrenoceptor agonist which is useful for treatment of respiratory diseases.

CHIR 2279
(CAS: 158198-45-9)

CHIR 2279, an isoquinolin derivative, was once studied against hypertension as an α1 adrenergic receptor antagonist.

Chemical Structure

CAS 849-55-8 Nylidrin hydrochloride

Quick Inquiry

Verification code

Featured Items